MarketInOut Stock Screener Log In | Sign Up

eXoZymes Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
eXoZymes Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization35.36 mln
Float3.00 mln
Earnings Date11/13/2026

Relative Strength

67 / 100
Outperforming

Debt / Equity

0.30
Low leverage

ROE

-240
Deeply negative

ROA

-144
Deeply negative

Business Description

Founded in 2014 and based in Monrovia, California, eXoZymes Inc. is an early-stage biotech company working to build better tools for biological manufacturing. The company creates enzyme-based systems that work outside of living cells, offering a cleaner and more controlled approach to producing chemicals and materials. Previously operating under the name Invizyne Technologies Inc., the company adopted its current name in early 2025.

Key Fundamentals

EPS-1.19
ROE-240
ROIC-447
ROA-144
EBITDA, mln-10.00
EV / EBITDA-4.43
EV / EBIT-4.30

Quote Details

Last 4.13
Change 0.02 (0.49%)
Open 4.18
Volume 6,113
Turnover 25,247
Average Volume 12,880

Financial Ratios

Leverage Ratio2.18
Current Ratio3.81
Price / Book14.95
Price / Tangible Book14.95
Debt / Equity0.30

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.25% 84 / 100   
1 Month -28.3% 12 / 100   
2 Months -9.23% 33 / 100   
6 Months -57.64% 10 / 100   
1 Year -67.2% 13 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog